Home > Healthcare > Pharmaceuticals > Finished Drug Form > U.S. Medical Marijuana Market

U.S. Medical Marijuana Market Analysis

  • Report ID: GMI2890
  • Published Date: Oct 2022
  • Report Format: PDF

U.S. Medical Marijuana Market Analysis

U.S. Medical Marijuana Market Share By Application

To understand key trends  
Download Free Sample

U.S. medical marijuana market from pain management segment was over USD 7 billion in 2021. Rising incidences of neuropathic and chronic pain cases in the U.S. has accelerated the need for novel therapeutic options. According to data provided by the CDC, more than 20% of American adults live with chronic pain. Marijuana is seen as a potential alternative to traditional chronic pain medication.

Studies suggest that medical marijuana may be a good treatment option for people with fibromyalgia as it contains compounds that could offer relief from some of its symptoms. Patients of fibromyalgia may experience pain and headaches along with several other indications. Government efforts to legalize the substance for medical purposes will enable its use in the production of novel chronic pain medications.

In terms of the distribution channel, the U.S. medical marijuana market is bifurcated into dispensaries, and online platforms. The dispensaries segment is projected to exhibit a 10% CAGR between 2022-2030. Several U.S. states are allowing patients to purchase medical marijuana products from authorized local dispensaries. Authorized procurement and sale of cannabis-infused medical products helps the local governments to effectively check whether the distribution is performed legally. Increasing initiatives in favor of marijuana legalization will enable the deployment of authorized dispensaries in the country.

U.S. Medical Marijuana Market By Zones

To understand key market trends  
Download Free Sample

South Atlantic U.S. medical marijuana market is poised to surpass USD 3 billion by 2030. Significant progress in the patient population across the state will fuel the demand for suitable CBD products. A favorable licensing scenario is accelerating cannabis production across South Atlantic. Increasing awareness regarding the health benefits of the substance will further drive the sales of medical marijuana across South Atlantic U.S.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. market for medical marijuana was valued at over USD 9 billion in 2021 and is projected to expand at more than 10% CAGR between the estimated timeframe of 2022-2030.

Pain management applications was over USD 7 billion in 2021 due to the rise in the number of patients with chronic and neuropathic pain in the U.S.

South Atlantic U.S. medical marijuana market size is anticipated to exceed USD 3 billion by 2030 owing to increasing efforts to boost the production of cannabis products.

Tilray, Curaleaf, Green Roads, CHARLOTTE’S WEB, Gaia Herbs, Medical Marijuana, and Folium Biosciences are some of the leading companies in the U.S. market.

U.S. Medical Marijuana Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 16
  • Tables & Figures: 413
  • Countries covered: 36
  • Pages: 225
 Download Free Sample